These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 34885242)
21. Prognostic value of preoperative albumin-to-alkaline phosphatase ratio in patients with surgically treated urological cancer: a systematic review and meta-analysis. Ren S; Wang H; Yang B; Zheng Y; Ou Y; Bao Y; Mao Y; Feng Y Front Oncol; 2023; 13():1236167. PubMed ID: 38023164 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of the albumin-to-alkaline phosphatase ratio on urologic outcomes in patients with non-metastatic renal cell carcinoma following curative nephrectomy. Xia A; Chen Y; Chen J; Pan Y; Bao L; Gao X J Cancer; 2019; 10(22):5494-5503. PubMed ID: 31632493 [No Abstract] [Full Text] [Related]
23. Association Between the Pretreatment Albumin-to-Alkaline Phosphatase Ratio and Clinical Outcomes in Patients With Bladder Cancer Treated With Radical Cystectomy: A Retrospective Cohort Study. Li S; Lu S; Liu X; Chen X Front Oncol; 2021; 11():664392. PubMed ID: 33959511 [TBL] [Abstract][Full Text] [Related]
24. Hyponatremia in lung cancer: Incidence and prognostic value in a Danish population-based cohort study. Sandfeld-Paulsen B; Aggerholm-Pedersen N; Winther-Larsen A Lung Cancer; 2021 Mar; 153():42-48. PubMed ID: 33454516 [TBL] [Abstract][Full Text] [Related]
25. Albumin-to-alkaline phosphatase ratio: A novel prognostic index of overall survival in cholangiocarcinoma patients after surgery. Xiong JP; Long JY; Xu WY; Bian J; Huang HC; Bai Y; Xu YY; Zhao HT; Lu X World J Gastrointest Oncol; 2019 Jan; 11(1):39-47. PubMed ID: 30984349 [TBL] [Abstract][Full Text] [Related]
26. The Prognostic Significance Of Pretreatment Albumin/alkaline Phosphatase Ratio In Patients With Stage IB-IIA Cervical Cancer. Zhang C; Li Y; Ji R; Zhang W; Zhang C; Dan Y; Qian H; He A Onco Targets Ther; 2019; 12():9559-9568. PubMed ID: 32009792 [TBL] [Abstract][Full Text] [Related]
27. Low albumin-to-alkaline phosphatase ratio is associated with inferior prognosis in patients with head and neck cancer underwent concurrent chemoradiation: A propensity score-matched analysis. Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Nam J J Cancer Res Ther; 2023; 19(5):1340-1344. PubMed ID: 37787305 [TBL] [Abstract][Full Text] [Related]
28. Prognostic Value of Albumin-to-Alkaline Phosphatase Ratio in Hepatocellular Carcinoma Patients Treated with Liver Transplantation. Li H; Wang L; Chen L; Zhao H; Cai J; Yao J; Zheng J; Yang Y; Wang G J Cancer; 2020; 11(8):2171-2180. PubMed ID: 32127944 [No Abstract] [Full Text] [Related]
29. Albumin-to-Alkaline Phosphatase Ratio: A Novel Prognostic Index of Overall Survival in Cisplatin-based Chemotherapy-treated Patients with Metastatic Nasopharyngeal Carcinoma. Nie M; Sun P; Chen C; Bi X; Wang Y; Yang H; Liu P; Li Z; Xia Y; Jiang W J Cancer; 2017; 8(5):809-815. PubMed ID: 28382143 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of dynamic albumin-to-alkaline phosphatase ratio in limited stage small-cell lung cancer. Li X; Li B; Zeng H; Wang S; Sun X; Yu Y; Wang L; Yu J Future Oncol; 2019 Mar; 15(9):995-1006. PubMed ID: 30644319 [TBL] [Abstract][Full Text] [Related]
31. Validation of the Prognostic Value of Preoperative Albumin-to-Alkaline Phosphatase Ratio in Patients with Surgically Treated Non-Metastatic Renal Cell Carcinoma. Hu X; Yang ZQ; Dou WC; Shao YX; Wang YH; Lia T; Li X Onco Targets Ther; 2020; 13():8287-8297. PubMed ID: 32903862 [TBL] [Abstract][Full Text] [Related]
32. Clinical role of pretreatment albumin-to-alkaline phosphatase ratio in lung cancer: a meta-analysis. Yang Y; Wang Y; Li X; Xie X Sci Rep; 2024 Jan; 14(1):1166. PubMed ID: 38216656 [TBL] [Abstract][Full Text] [Related]
33. The prognostic significance of Albumin-to-Alkaline Phosphatase Ratio in upper tract urothelial carcinoma. Tan P; Xie N; Ai J; Xu H; Xu H; Liu L; Yang L; Wei Q Sci Rep; 2018 Aug; 8(1):12311. PubMed ID: 30120312 [TBL] [Abstract][Full Text] [Related]
34. Albumin-to-Alkaline Phosphatase Ratio is an Independent Prognostic Indicator in Combined Hepatocellular and Cholangiocarcinoma. Zhang F; Lu S; Tian M; Hu K; Chen R; Zhang B; Ren Z; Shi Y; Yin X J Cancer; 2020; 11(17):5177-5186. PubMed ID: 32742464 [No Abstract] [Full Text] [Related]
35. Prognostic significance of albumin to alkaline phosphatase ratio in critically ill patients with acute kidney injury. Xia W; Zhao D; Li C; Xu L; Yao X; Hu H Clin Exp Nephrol; 2022 Sep; 26(9):917-924. PubMed ID: 35579723 [TBL] [Abstract][Full Text] [Related]
36. Albumin-to-alkaline phosphatase ratio as a promising indicator of prognosis in human cancers: is it possible? An L; Yin WT; Sun DW BMC Cancer; 2021 Mar; 21(1):247. PubMed ID: 33685425 [TBL] [Abstract][Full Text] [Related]
37. Albumin-to-Alkaline Phosphatase Ratio as an Independent Prognostic Factor for Overall Survival of Advanced Hepatocellular Carcinoma Patients without Receiving Standard Anti-Cancer Therapies. Cai X; Chen Z; Chen J; Ma X; Bai M; Wang T; Chen X; Wu D; Wei L; Li X; Lin Q; Wen J; Ruan D; Lin Z; Dong M; Wu X J Cancer; 2018; 9(1):189-197. PubMed ID: 29290785 [No Abstract] [Full Text] [Related]
38. Decreased albumin-to-alkaline phosphatase ratio predicted poor survival of resectable gastric cancer patients. Wang Y; Xiong F; Yang J; Xia T; Jia Z; Shen J; Xu C; Feng J; Lu Y J Gastrointest Oncol; 2021 Aug; 12(4):1338-1350. PubMed ID: 34532092 [TBL] [Abstract][Full Text] [Related]
39. Albumin-to-alkaline phosphatase ratio as a predictor of tumor recurrence and prognosis in patients with early-stage hepatocellular carcinoma undergoing radiofrequency ablation as initial therapy. Zhang F; Lu SX; Hu KS; Gan YH; Chen Y; Ge NL; Yang BW; Zhang L; Chen RX; Ren ZG; Yin X Int J Hyperthermia; 2021; 38(1):1-10. PubMed ID: 33400889 [TBL] [Abstract][Full Text] [Related]
40. Albumin-To-Alkaline Phosphatase Ratio as a Novel and Promising Prognostic Biomarker in Patients Undergoing Esophagectomy for Carcinoma: A Propensity Score Matching Study. Zhu X; Chen D; Li S; Zhang W; Li Y; Wang X; Zhou J; Wen Z Front Oncol; 2021; 11():764076. PubMed ID: 34746006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]